返回
Differentially secure multicasting and its implementation methods
DOI:10.1016/S0167-4048(02)00814-3.png)
摘要
En 中文
Though the areas of secure multicast group architecture, key distribution and sender authentication are under scrutiny, one topic that has not been explored is how to integrate these with multi-level security. Multi-level security is the ability to distinguish subjects according to classification levels, which determines to what degree they can access confidential objects. In the case of groups, this means that some members can exchange messages at a higher sensitivity level than others. The Bell-La Padula model [BL76] outlines the rules of these multi-level accesses. In multicast groups that employ multi-level security, some of these rules are not desirable so a modified set of rules is developed in this paper and is termed differential security. Also, this paper proposes three methods to set up a differentially secure multicast group: (i) Naive approach, (h) multiple tree differential security (DiffSec) approach, mid (W) single DiffSec tree approach. In order to evaluate the performances (in terms of the number of links used per packet transmitted) of these approaches, extensive simulation experiments were conducted by varying the network connectivity and group size for both uniform and non,uniform. membership distribution across security levels. Our studies show that the multiple tree and single DiffSec tree approaches perform much better than the Naive approach. While the multiple tree approach could be implemented using current technology, this scheme consumes many times more addresses and network resources than the single DiffSec tree approach. From our studies, we conclude that the single DiffSec tree is a viable option for supporting multi-level security as it maximizes the resource utilization and is also scalable.
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
C
IF:
5.4
论文数:
4.6K
被引数:
1.4W
机构
暂无机构信息
引用论文
A clearer distinction between HIV-1 paired isolates from peripheral blood mononuclear cells of asymptomatic carriers with and without CD8+ T-cells at nef rather than env V3 loci
Vaccine
IF0

